9.27.22 | Autoimmune
Education and Access Play Key Role for Improving Well-being for Women Living with Autoimmune Diseases
These are takeaways from SWHR's August 2022 meeting of an interdisciplinary group of policy experts, researchers, clinicians, and patient advocates in women’s autoimmune and immune-mediated diseases.
9.2.22 | Lupus
Closing the Loop for Lupus: A Fireside Chat
The event discussed how to improve health outcomes for individuals with lupus through recognizing and addressing symptoms, comorbidities, treatment options, and barriers to accessing quality care, while highlighting the diverse experiences of women living with lupus.
8.8.22 | Autoimmune
Empowerment through Diagnosis: Improving Livelihoods for Women Living with Psoriatic Arthritis
SWHR gathered psoriatic arthritis health care providers, researchers, patients and patient advocates in June 2022 to discuss the health, social, and economic impacts of PsA on women’s health across the lifespan.
7.27.22 | Autoimmune
Addressing Barriers to Care for Women with Autoimmune Diseases and Conditions
SWHR convened an interdisciplinary Autoimmune Policy Working Group to discuss policy needs and opportunities as they relate to women’s autoimmune and immune-mediated diseases and conditions across the lifespan.
7.20.22 | Autoimmune
Psoriatic Arthritis: More than Just Sore Joints
This event discussed how to improve health outcomes for individuals with psoriatic arthritis through recognizing and addressing symptoms, comorbidities, treatment options, and barriers to accessing quality care, while highlighting the diverse experiences of women across the lifespan.
7.19.22 | Autoimmune
New SWHR Paper Strives to Address Skin Disease Burden for Women
This commentary on skin disease burden in the journal Women’s Health Issues aims to advance understanding and awareness of autoimmune skin diseases in women.
7.18.22 | Autoimmune
Utilization Management Policies and Autoimmune Diseases: A Women’s Health Issue
The rate of autoimmune diseases and conditions in the United States is rising—and women are disproportionately affected: 80% of patients […]
